Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Enterobacter amnigenus. An unusual human pathogen]

J A Capdevila1, V Bisbe, I Gasser

  • 1Servicio de Enfermedades Infecciosas, Hospital General Universitari Vall d'Hebron, Universitat Autònoma, Barcelona. janton@ar.vhebron.es

Enfermedades Infecciosas Y Microbiologia Clinica
|December 3, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flow injection hydride generation electrothermal atomic absorption spectrometry with in-atomizer trapping for the determination of lead in calcium supplements.

Talanta·2008
Same author

[Pneumoperitoneum with intramural gas in a bowel segment].

Revista espanola de enfermedades digestivas·2008
Same author

[Preoperative workup to assess indication for laparoscopic treatment in gastroesophageal reflux disease].

Revista espanola de enfermedades digestivas·2008
Same author

Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.

The Journal of antimicrobial chemotherapy·2008
Same author

Optimization of microwave-assisted extraction with saponification (MAES) for the determination of polybrominated flame retardants in aquaculture samples.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2008
Same author

Tigecycline for Acinetobacter baumannii infection: other considerations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2008
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Enterobacter amnigenus, previously considered non-pathogenic, can cause documented human infections. This bacterium exhibits antimicrobial susceptibility patterns similar to Enterobacter cloacae.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Bacterial pathogenesis

Background:

  • Enterobacter amnigenus is a bacterium with uncertain pathogenic potential.
  • A case of documented E. amnigenus infection prompted a review of its clinical significance.

Observation:

  • A retrospective study analyzed 15 E. amnigenus isolates over 46 months.
  • Clinical data allowed classification of E. amnigenus as the definitive, probable, or improbable cause of infection in 7 patients.

Findings:

  • E. amnigenus was definitively linked to infection in 4 out of 7 evaluated patients.
  • High resistance rates were observed for ampicillin (83%) and cefazoline/cefoxitine (75%).
  • All isolates remained susceptible to third-generation cephalosporins, aztreonam, ciprofloxacin, cotrimoxazole, and aminoglycosides.

Related Experiment Videos

Implications:

  • E. amnigenus should be recognized as a potential cause of bacterial infection, not merely a contaminant.
  • The clinical presentation and antibiotic susceptibility profile of E. amnigenus resemble those of Enterobacter cloacae.
  • This finding necessitates careful consideration of E. amnigenus in clinical diagnostics and treatment decisions.